Vijaya Diagnostic Centre
1,059.20
+16.80(+1.61%)
Market Cap₹10,880.63 Cr
PE Ratio70.34
Company Performance:
1D+1.61%
1M+5.70%
6M+8.02%
1Y-0.33%
5Y+70.81%
View Company Insightsright
More news about Vijaya Diagnostic Centre
18Oct 25
Vijaya Diagnostic Centre Announces CTO Resignation and NCLT Approval for Medinova Merger
Vijaya Diagnostic Centre Limited (VDCL) has announced two significant changes. The company's CTO, Mr. Srinivas Lanka, has resigned effective November 15, 2025, citing personal reasons. Additionally, VDCL has received NCLT approval for its merger with Medinova Diagnostic Services Limited (MDSL). The merger's effective date is pending filing with the Registrar of Companies, Hyderabad. A record date for share allotment to MDSL shareholders will be announced later.
16Oct 25
NCLT Approves Amalgamation of Medinova Diagnostic Services with Vijaya Diagnostic Centre
The NCLT Hyderabad Bench has approved the amalgamation of Medinova Diagnostic Services Limited with Vijaya Diagnostic Centre Limited. The merger, sanctioned on October 13, 2025, with an appointed date of April 1, 2024, involves a share exchange ratio of 1:22. Vijaya Diagnostic Centre's existing 62.14% stake in Medinova will be cancelled. The merger aims to consolidate operations, create synergies, reduce costs, and improve efficiency in the diagnostic services sector. The order ensures regulatory compliance, protects stakeholder interests, and safeguards employee rights. Medinova will be dissolved without winding-up.
01Oct 25
Vijaya Diagnostic Centre's Operations VP to Step Down in November 2025
V. Siva Rama Raju Vegesna, Vice President of Operations at Vijaya Diagnostic Centre, has resigned citing personal reasons. His resignation will be effective from November 8, 2025. Vegesna has been with the company for over six years, contributing to investor relations, strategic initiatives, and market expansion. The company has expressed appreciation for his service and has approximately a year to manage the transition.
29Sept 25
NCLT Hyderabad Reserves Order on Vijaya Diagnostic-Medinova Merger
The National Company Law Tribunal (NCLT) in Hyderabad has reserved its order on the proposed merger between Vijaya Diagnostic Centre Limited and Medinova Diagnostic Services Limited. The merger, with an appointed date of April 1, 2024, is based on a going concern basis under Sections 230 to 232 of the Companies Act, 2013. Vijaya Diagnostic Centre has reported that the attendance-cum-order sheet recording the 'Orders Reserved' status is available on the NCLT website. The company awaits the certified true copy of the order to submit to stock exchanges.
02Aug 25
Vijaya Diagnostic Centre Reports 20.4% Revenue Growth in Q1
Vijaya Diagnostic Centre reported consolidated revenue of Rs. 188.00 crores for Q1, a 20.4% year-on-year growth. The company saw a 17% increase in test volume and 14% rise in patient footfall. EBITDA margin was 39.1% and PAT margin 20.4%. The core Hyderabad market returned to double-digit growth. Five new hubs and one spoke were commissioned across Pune, Bangalore, and West Bengal. The company maintains a strong financial position with a cash balance of Rs. 270.00 crores. Future plans include opening 10 hubs in the current financial year with a CAPEX of Rs. 150.00-155.00 crores for new centers.
28Jul 25
Vijaya Diagnostic Centre Announces Robust Q1 Results and Ambitious Expansion Plans
Vijaya Diagnostic Centre reported impressive Q1 results with 20.4% revenue growth to Rs 1,880.50 crore, 20.1% EBITDA growth to Rs 735.30 crore, and 22.3% PAT growth to Rs 383.40 crore. The company performed 3.94 million tests, a 16.7% increase, with 1.10 million footfalls. Expansion plans include launching 3 new hubs in Q2 and 2 more in West Bengal later this fiscal year. The company aims to achieve break-even across all centers within 12 months, with one Bengaluru hub progressing faster than expected.
28Jul 25
Vijaya Diagnostic Centre Reports Robust Q1 FY26 Performance with 20.5% Revenue Growth
Vijaya Diagnostic Centre announced strong Q1 FY26 results with revenue increasing 20.5% to ₹188.05 crore. Net profit rose 23.1% to ₹38.59 crore, while EBITDA grew to ₹73.50 crore with a margin of 39.10%. The company granted 2,500 ESOPs, appointed a new Secretarial Auditor, and is progressing with a proposed merger with its subsidiary, Medinova Diagnostic Services Limited.
08Jul 25
Vijaya Diagnostic Centre Ltd. Sees Rs. 23.13 Crore Block Trade on NSE
A significant block trade of 230,405 shares of Vijaya Diagnostic Centre Ltd. was executed on the National Stock Exchange (NSE). The transaction was valued at Rs. 23.13 crore, with each share priced at Rs. 1,004.00. This large trade indicates potential shifts in ownership or strategic moves by major shareholders, although the identities of the buyer and seller remain undisclosed. Such transactions can influence market sentiment and the stock's trading pattern in the short term.
12May 25
Vijaya Diagnostic Centre Reports Q4 Growth in EBITDA and Net Profit, Declares Dividend
Vijaya Diagnostic Centre's Q4 results show significant growth across key financial metrics. Revenue increased by 26.05% to ₹173.70 crore, EBITDA rose by 29.60% to ₹71.80 crore, and net profit grew by 35.77% to ₹35.30 crore year-over-year. The company's EBITDA margin improved to 41.34%, and it declared a dividend of ₹2.00 per share. Operating profit reached ₹67.10 crore with a margin of 39.73%, indicating strong core operational performance.
Vijaya Diagnostic Centre
1,059.20
+16.80
(+1.61%)
1 Year Returns:-0.33%
Industry Peers
Dr. Lal Path Labs
1,474.20
(-2.36%)
Vijaya Diagnostic Centre
1,059.20
(+1.61%)
Metropolis Healthcare
1,933.30
(+1.92%)
Krsnaa Diagnostics
733.35
(-0.96%)
Suraksha Diagnostic
276.65
(+1.28%)
3B BlackBio DX
1,414.25
(-0.03%)
Sastasundar Ventures
315.75
(+7.07%)